Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_assertion description "[Delineation of the adverse prognostic power of MDR1 in adult acute myeloid leukemia (AML) raised hopes that pharmacologic blockade of P-gp would improve the outcome of conventional cytotoxic therapy, perhaps more so than in any other human malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_assertion evidence source_evidence_literature NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_assertion SIO_000772 15217827 NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_assertion wasDerivedFrom befree-20140225 NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_assertion wasGeneratedBy ECO_0000203 NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP559247.RAWPpVVPACXsw_frsjNW6VBbUy3pZKxj1pNSNHKBbgFBw130_provenance.